Investing.com -- The latest tariffs imposed by the Trump administration are not a major concern for the China healthcare ...

Over 25 employers from across the Engineering sector recently attended the annual School of Engineering Careers Fair ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

India has long harbored ambitions to become a manufacturing powerhouse ... Get local news you need to know to start your day with NBC 6's News Headlines newsletter. In 2020, the Indian government ...

We forecast WuXi's revenue growth to be slower than that of other well-established peers. The risk is high that the US Biosecure Act will become law, and we expect global pharmaceutical or ...

WuXi Biologics (Cayman) Inc., a leading global Contract Research, Development and Manufacturing Organization service company offering end-to-end solutions for biologics discovery, development and ...

Revenue grew 9.6% YoY to RMB ... Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization ...

HONG KONG, March 25, 2025 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269), a leading global Contract Research, Development and Manufacturing ...

SHANGHAI, March 23, 2025 /PRNewswire/ -- WuXi Biologics ... project completed in just 6 months. By leveraging single-use technology (SUT), the company scaled manufacturing from 4,000 to 16,000 ...